Dr Wei Li is a British Heart Foundation Lecturer in Vascular Biology, based at the Department of Medicine, University of Cambridge. She obtained her PhD at University of East Anglia under the supervision of Prof. Colin Kleanthous and in the field of kinetics and thermodynamics of protein-protein interaction and protein engineering. She subsequently did postdocs with Prof. Jim Huntington in the field of protein biochemistry and protein crystallography, characterized human proteins including full-length huntingtin and serpin family protease inhibitors. She became a BHF lecturer in 2010 and started working on the mechanisms of bone morphogenetic protein regulation, using a range of approaches including biochemistry, protein engineering, crystallography as well as cell signalling and functional assays. Together with Prof. Nick Morrell and Dr Paul Upton, she is a co-founder of MORPHOGEN-IX, a spinoff company to develop bone morphogenetic proteins as a novel therapy for the treatment of pulmonary arterial hypertension.